Your Health Magazine Contributor
4201 Northview Drive
Suite #102
Bowie, MD 20716
301-805-6805
More Health News & Research Articles
Is Using Peptides That Are Not FDA Approved a Dangerous Wellness Trend?
The growing popularity of peptides shouldn’t come as a surprise. The pharmaceutical product is being promoted as an anti-aging tool, weight-loss solution, and muscle recovery booster, which means it offers something desirable to virtually every segment of the population.
But as with many wellness trends, the promotion of peptides often doesn’t adequately inform people about the potential downsides. Regular peptide injections, regardless of the goal, come with risks.
Many of the peptides on the market today, including those being used to build muscle mass and reduce the effects of aging, are not approved by the US Food and Drug Administration (FDA). Consequently, their long-term side effects haven’t been officially tested, and their long-term safety hasn’t been affirmed.
“Peptide medicine is the fastest-growing area of modern medicine and the least regulated in the country,” says Karthik Achari, Clinician and Founder of PepMD. “Thousands of clinics and tens of thousands of providers are prescribing peptides every day with no real standard for who’s qualified, where the product is coming from, or whether anyone is tracking how patients actually do on them. Right now, patients have no way to tell a qualified clinician from someone with a good website, and clinicians doing this the right way have no way to stand apart. That’s not a science problem. The science is real. It’s a structural problem, and patients are the ones absorbing the risk.”
Achari is a clinician with a background in pharmaceutical infrastructure, where he saw firsthand the need for greater accountability and consistency in the peptide and GLP-1 space. He founded PepMD in 2026 to address the lack of infrastructure needed to support the rapid growth of peptide medicine. PepMD credentials clinicians, recognizes pharmacies, and authorizes research sites under a single, unified standard.
What are injectable peptides and their potential benefits?
Peptides are short chains of amino acids, which are the same basic human building blocks that make up proteins. The body produces thousands of peptides naturally, using them to regulate everything from metabolism to immune response to tissue repair. However, conditions like aging, stress, or illness can cause natural production to decline.
Synthetic peptides have been around for decades, with many gaining FDA approval as treatments for conditions caused by peptide deficiencies. Lab-produced insulin is one of those peptides, as are peptide-based semaglutides used to treat Type 2 diabetes.
“Peptides are not a new or fringe idea in medicine,” Achari explains. “Insulin is a peptide. Ozempic and Wegovy are peptides. Several cancer drugs are peptides. They’ve been FDA-approved and used safely for decades, prescribed by doctors and produced under strict manufacturing standards. The wellness market has zeroed in on a different group: peptides like BPC-157, TB-500, and sermorelin that do have real research behind them, but aren’t FDA-approved for the ways they’re being marketed. The science on some of them is genuinely promising. The problem is that almost none of it is happening inside a real medical framework right now.”
The synthetic peptides that have become popular today are mostly used to address the body’s natural decline, such as those that deliver anti-aging effects or improve skin health, and to push processes like muscle growth beyond the body’s natural capacity.
What are the potential risks of using the type of peptides that are not FDA-approved?
As peptide use has shifted from a medical procedure overseen by healthcare providers to a wellness trend driven by influencers, the medical community has become increasingly concerned about its use. For example, a recent publication from the American Medical Association (AMA) titled “What Doctors Wish Patients Knew About Injectable Peptides” points to a number of concerns users may not be aware of, including the fact that many peptides sold for wellness and recovery have been tested on animal models but not humans.
“Most of what gets called ‘peptide research’ right now isn’t research at all. It’s people experimenting on themselves, or on paying clients, with no safety oversight, no clinical protocol, no informed consent, and no records being kept,” Achari points out. “There’s no review board, no principal investigator, and no one tracking outcomes or reporting when something goes wrong. That’s self-experimentation dressed up in research language, and patients have no way to tell the difference between that and an actual medical study. The clinicians doing this responsibly get lumped in with everyone else, which is part of why the field hasn’t built the trust it deserves.”
Supply chain issues related to peptides raise another health concern. The same peptide molecule can come from a US research manufacturer with rigorous quality controls or from a vendor with none, and getting information on the source of the product you are using can be challenging.
“When independent labs have tested peptides being sold online, they keep finding the same problems over and over: contamination, mislabeled doses, products that are weaker than the label claims, and, in some cases, bottles with no active ingredient at all,” Achari warns. “The same peptide can come from a serious US manufacturer with quality controls and third-party testing, or from a vendor with zero oversight, and most patients have no way to tell which one they’re holding. That’s the part of this conversation people aren’t having yet. You can be injecting the right molecule, the wrong dose, the wrong purity, or something that isn’t even what the label says it is, and you’d have no way of knowing until something went wrong.”
The current peptide craze is also raising concerns about the lack of clinical oversight. Traditional peptide therapies are administered by trained physicians in a clinical setting, and their oversight ensures that dosages are correct and that peptide effects are normal.
“Most people using peptides for wellness are injecting themselves at home, often based on advice from a forum or a creator they follow,” Achari says. “But that means there’s no bloodwork beforehand to establish a baseline, no clinician monitoring liver enzymes, kidney function, or hormone levels while they’re on it, and no one tracking side effects or watching for the early signs of something going wrong. If a problem develops, there’s no medical record showing what they took, no provider following up, and no system to report it back to so the next patient learns from it. The data just disappears.”
Peptide production and use are outpacing oversight efforts
Media reports continue to show peptide popularity growing, but stories are also emerging that highlight the dangerous side effects some are experiencing. Experts believe risks are increasing primarily because production and use are outpacing oversight. The solution, they say, is more informed and consistent oversight of the peptide market.
“The wellness peptide market has grown a lot faster than the rules and standards around it,” Achari says. “The peptides themselves aren’t all dangerous, and the science is real. The system delivering them to patients is where this falls apart. Until there’s a clear, recognized standard for which clinicians are qualified to prescribe, which pharmacies meet real quality requirements, and which research programs are actually legitimate, patients are basically figuring it out on their own and hoping for the best. The fix isn’t complicated, even if it takes work to build. Trained, credentialed clinicians. Vetted, recognized pharmacies. Real, IRB-overseen research. That’s what responsible peptide medicine looks like, and it’s what patients deserve.”
Other Articles You May Find of Interest...
- Is Using Peptides That Are Not FDA Approved a Dangerous Wellness Trend?
- Pooled Human Hepatocytes: Improving Drug Metabolism Studies with Diverse Donor Profiles
- How Researchers Measure Intracellular Glutathione Levels In Preclinical Studies
- Chemistry Reagents: What They Are, What They Do, and Why How You Handle Them Decides Everything
- A Practical Peptide Selection Guide For Laboratory Buyers
- What Is Cardarine (GW-501516)? A Preclinical Research Overview
- Troubleshooting Common ELISA Immunoassay Kit Errors









